Related Experiment Video
Updated: Oct 25, 2026

Catheter Ablation in Combination With Left Atrial Appendage Closure for Atrial Fibrillation
Published on: February 26, 2013
Atrial Fibrillation Pattern and Outcomes After Contemporary Left Atrial Appendage Occlusion
Background:
Atrial fibrillation (AF) pattern predicts thromboembolic risk during anticoagulation, but its prognostic importance after left atrial appendage occlusion (LAAO) is uncertain.
Objectives:
To determine whether AF pattern independently predicts residual clinical risk after contemporary LAAO and whether peri-device leak (PDL) or device-related thrombus (DRT) identify a persistently high-risk subgroup.
Methods:
We studied 3,459 patients with documented AF pattern undergoing LAAO in a contemporary multicenter registry. AF was classified as paroxysmal, persistent or long-standing persistent, or permanent. The primary endpoint was a 2-year hierarchical composite of death, stroke or systemic embolism (stroke/SE), and major bleeding analyzed by win ratio. Inverse probability weighting and propensity score methods adjusted for baseline differences. Follow-up imaging assessed PDL and DRT.
Results:
After inverse probability weighting, persistent and permanent AF were associated with progressively worse hierarchical outcomes compared with paroxysmal AF (win ratios 1.39 and 1.59, respectively). Non-paroxysmal AF was associated with higher stroke risk (HR 1.64; 95% CI 1.07-2.50), without increased mortality or major bleeding. PDL and DRT were more frequent in non-paroxysmal AF. In the PDL/DRT subgroup, non-paroxysmal AF was associated with higher first stroke/SE risk (HR 1.83; 95% CI 1.00-3.34), concentrated 180-540 days after LAAO.
Conclusions:
AF pattern independently stratified residual clinical risk after LAAO, with progressively worse severity-weighted outcomes from paroxysmal to persistent and permanent AF. Excess risk was driven primarily by thromboembolism. In the PDL/DRT subgroup, the association was concentrated 180-540 days after LAAO, suggesting these patients may benefit from prolonged thromboembolic surveillance.

